688235 (688235) News
Follow 688235 (688235) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
BeOne Medicines Reports Improved Survival in Phase 3 Cancer Study
The company said a combination treatment improved overall survival among patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma.
EQUITY | Oct 23, 2026, 03:47 PM UTC
L
BeOne Medicines maintained at overweight by Barclays
EQUITY | Sep 10, 2026, 01:18 PM UTC
L
BeOne Medicines signs cancer drug pricing agreement with US government
BeOne Medicines has signed a cancer drug pricing agreement with the US government, according to TradingView News.
EQUITY | Aug 31, 2026, 07:19 PM UTC
L
BeOne Medicines announces voluntary U.S. government agreement to expand cancer medicine access
BeOne Medicines said it reached a voluntary agreement with the U.S. government to expand access to innovative cancer medicines.
EQUITY | Aug 31, 2026, 07:00 PM UTC